SavedAdd your journal

Journals / Türk Hijyen ve Deneysel Biyoloji Dergisi / 2022 / Cilt: 79 - Sayı: 2

Acinetobacter baumannii strains grown in endotracheal aspirate culture in Samsun Bafra State Hospital intensive care units and the effect of COVID-19 on Acinetobacter baumannii strains (2019-2020)

Samsun Bafra Devlet Hastanesi yoğun bakım ünitelerinde endotrakeal aspirat kültüründe üreyen Acinetobacter baumannii suşları ve COVID-19 etkisi (2019-2020)

Seda GÜDÜL HAVUZ
Pages
229–242
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The mean age and standard deviations of 18 patients before the COVID-19 pandemic and 56 patients after the pandemic were found to be 83,0 ± 8,3 and 70,5 ± 14,9 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Acinetobacter baumannii is an important causative agent of ventilation-associated pneumonia capable of long-term survival in the hospital setting.
📊
Key Findings & Data:In this study, the antibiotic resistance profiles of A. baumannii strains grown in endotracheal aspirate (ETA) cultures in intensive care units and the effect of the COVID-19 pandemic on the resistance profiles in our province where the highest number of cases were observed in our country for a long time were investigated.
💡
Conclusion & Impact:Results: The mean age and standard deviations of 18 patients before the COVID-19 pandemic and 56 patients after the pandemic were found to be 83,0 ± 8,3 and 70,5 ± 14,9 (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Acinetobacter baumannii is an important causative agent of ventilation-associated pneumonia capable of long-term survival in the hospital setting. Increasing resistance to antibiotics effective against this pathogen is of concern. In this study, the antibiotic resistance profiles of A. baumannii strains grown in endotracheal aspirate (ETA) cultures in intensive care units and the effect of the COVID-19 pandemic on the resistance profiles in our province where the highest number of cases were observed in our country for a long time were investigated. Methods: Our study included 74 A. baumannii isolates isolated from ETA samples that was sent to our laboratory from the intensive care units of Bafra State Hospital between January 2019 and December 2020. Bacteria were identified using conventional methods and a semi automatic bacterial identification system Vitek-2 (bioMérieux, France). The antibiotic susceptibility tests of the isolated strains were studied in accordance with the European Committee for Antimicrobial Susceptibility Testing (EUCAST) standards. Antibiotic susceptibility of A. baumannii strains was tested with Vitek-2 system. Results: The mean age and standard deviations of 18 patients before the COVID-19 pandemic and 56 patients after the pandemic were found to be 83,0 ± 8,3 and 70,5 ± 14,9 (p

Özet

Amaç: Acinetobacter baumannii, hastane ortamında uzun süre yaşama yeteneğine sahip ventilasyon ile ilişkili pnömoninin önemli bir etkenidir. Bu patojene etkili olan antibiyotiklere karşı artan direnç endişe yaratmaktadır. Bu çalışmada yoğun bakım ünitelerinde endotrekeal aspirat (ETA) kültürlerinde üreyen A. baumannii suşlarının antibiyotik direnç profilleri ve uzun süre ülkemizde en çok vakanın görüldüğü ilimizde COVID-19 pandemisinin direnç profilleri üzerindeki etkisi incelenmiştir. Yöntem: Çalışmamıza, Ocak 2019 ile Aralık 2020 tarihleri arasında Bafra Devlet Hastanesi yoğun bakım ünitelerinden laboratuvarımıza gönderilen ETA örneklerinden izole edilen toplam 74 adet A. baumannii izolatı dahil edilmiştir. Konvansiyonel yöntemler ve yarı otomatik bakteri tanımlama sistemi Vitek-2 (bioMérieux, Fransa) kullanılarak izole edilen A. baumannii suşlarının antibiyotik duyarlılıkları Avrupa Antimikribiyal Duyarlılık Test Komitesi - European Committee on Antimicrobial Susceptibility Testing (EUCAST) standartlarına uygun olarak Vitek-2 sistemi ile test edilmiştir. Bulgular: COVID-19 pandemisi öncesinde 18 hasta ile pandemi döneminde 56 hastanın ortalama yaş ve standart sapmaları sırasıyla 83,0 ± 8,3 ve 70,5 ± 14,9 (p

🔖

Cite This Article

HAVUZ, S. G. (2022). Acinetobacter baumannii strains grown in endotracheal aspirate culture in Samsun Bafra State Hospital intensive care units and the effect of COVID-19 on Acinetobacter baumannii strains (2019-2020). Türk Hijyen ve Deneysel Biyoloji Dergisi, Cilt: 79 - Sayı: 2, 229–242. https://ajindex.com/articles/624896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev, 2013;37(2):130-55
  2. Antimicrobial resistance global report on surveillance: 2014 Summary. Access date: 20.04.2021. Avaible from: https://www.who.int/ drugresistance/documents/surveillancereport /en/
  3. Emel A, Eraç B. Küresel bir tehdit: Acinetobacter baumannii enfeksiyonları, antimikrobiyal dirençte güncel durum ve alternatif tedavi yaklaşımları. Turk Hij Den Biyol Derg, 2020;77(3): 367-78
  4. Bacakoğlu F, Korkmaz Ekren P, Taşbakan MS, Başarik B, Pullukçu H, Aydemir S, ve ark. Solunumsal yoğun bakim ünitesinde çoklu antibiyotik dirençli Acinetobacter baumannii enfeksiyonu. Mikrobiyol Bul, 2009 Oct;43(4):575-85
  5. Piperaki E-T, Tzouvelekis L, Miriagou V, Daikos G. Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol Infect, 2019;25(8):951-7
  6. Jung J, Park W. Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives. Appl Microbiol Biotechnol, 2015;99(6):2533-48
  7. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 2008;21(3):538-82
  8. Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA, Jeda AS, et al. Bacterial co infections with SARS CoV 2. IUBMB life, 2020;72(10):2097-111
  9. Möhlenkamp S, Thiele H. Ventilation of COVID-19 patients in intensive care units. Herz, 2020;45(4):329-31
  10. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology, 2020;296(2):E15-E25
  11. Russotto V, Cortegiani A, Graziano G, Saporito L, Raineri SM, Mammina C, et al. Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria. Infect Drug Resist, 2015;8:287-96
  12. Garnacho-Montero J, Timsit J-F. Managing Acinetobacter baumannii infections. Curr Opin Infect Dis, 2019;32(1):69-76
  13. Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis, 2020;20(1):1-7
  14. Antimicrobial resistance surveillance in Europe. European Centre for Disease Prevention and Control 2013; Access date: 20.04.2021[Available from:https://www.ecdc.europa.eu/sites/ d e f a u l t / f i l e s / m e d i a / e n / p u b l i c a t